Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Moderna and Merck will jointly develop a cancer vaccine for high-risk melanoma patients By: CNBC.com News October 12, 2022 at 10:07 AM EDT Moderna's vaccine is being studied in combination with Merck's Keytruda to treat patients with high-risk melanoma, the deadliest form skin cancer. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Moderna and Merck will jointly develop a cancer vaccine for high-risk melanoma patients By: CNBC.com News October 12, 2022 at 10:07 AM EDT Moderna's vaccine is being studied in combination with Merck's Keytruda to treat patients with high-risk melanoma, the deadliest form skin cancer. Read More >>